Skip to content

TEAS to Improve Outcome During Emergence From General Anesthesia After Robotic Surgery

Effect of Transcutaneous Electrical Acupoint Stimulation on Outcome During Emergence From Anesthesia in Patients Undergoing Robotic Laparoscopic Gynecologic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02323958
Acronym
TIGER
Enrollment
150
Registered
2014-12-24
Start date
2014-12-31
Completion date
2016-12-31
Last updated
2017-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

This study is to observe whether transcutaneous electrical stimulation at specific acupoints could improve the quality of emergence in patients undergoing robotic laparoscopic gynecologic surgery.

Detailed description

During robotic laparoscopic gynecologic surgery, the patients are put in an extremely trendelenburg positon. And a long duration of this position could lead to delayed emergence or agitation. Stimulation at some acupoints were reported to improve homeostasis. In this study we tend to observe whether transcutaneous electrical stimulation at specific acupoints could improve the quality of emergence in patients undergoing robotic laparoscopic gynecologic surgery.

Interventions

stimulation is given at acupoints

stimulation is given at acupoints

OTHERelectrode attached

electrodes are attached to skin

DEVICEelectrical stimulation

electrical stimulation is given through electrodes attached to th skin

Sponsors

Air Force Military Medical University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for robotic laparoscopic gynecologic surgery under general anesthesia * Patients with written informed consent

Exclusion criteria

* Patients with difficulty in communication * Patients with disease of central nervous system

Design outcomes

Primary

MeasureTime frameDescription
Time to awakefrom end of inhaling sevoflurane to departing from postanesthesia care unit(PACU),an anticipated average of 1 hourtime to open eyes to verbal command

Secondary

MeasureTime frameDescription
Time to extubationfrom end of inhaling sevoflurane to departing from PACU,an anticipated average of 1 hour
QoR-15from end of inhaling sevoflurane to 24h after surgery,an anticipated average of 24 hourScore of quality of recovery using a 15 items questionaire
residual sedationfrom arriving at PACU to departing from PACU,an anticipated average of 30min
PONVfrom arriving at PACU to departing from PACU,an anticipated average of 30minpostoperative nausea and vomiting in the PACU
Richmond Scorefrom end of inhaling sevoflurane to departing from PACU,an anticipated average of 1 hourstatus of the patients during emergence
serum Aquaporin 4from before anesthesia to after surgery, an anticipated average of 4 hourslevel of serum Aquaporin 4 before anesthesia and at the end of the surgery
serum MMP9from before anesthesia to after surgery, an anticipated average of 4 hourslevel of serum Matrix metallop roteinase before anesthesia and at the end of the surgery
serum S100βfrom before anesthesia to after surgery, an anticipated average of 4 hourslevel of serum S100β before anesthesia and at the end of the surgery
VAS scorefrom arriving at PACU to departing from PACU,an anticipated average of 30minvisual analogue score of pain in the PACU, scored 0-10

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026